Deletion of the β2-adrenergic receptor39 and overexpression of a β-adrenergic receptor kinase 1 inhibitor40 has been shown to prevent the development of cardiomyopathy in MLP-deficient mice. The gene discussed is CSRP3; the disease is cardiomyopathy.